Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · IEX Real-Time Price · USD
6.56
+0.40 (6.49%)
At close: Mar 28, 2024, 4:00 PM
6.78
+0.22 (3.35%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $424.12 million as of March 28, 2024. Its market cap has increased by 27.98% in one year.
Market Cap
424.12M
Enterprise Value
161.28M
1-Year Change
27.98%
Ranking
Category
Stock Price
$6.56
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $406.10M to $424.12M, an increase of 4.44%. That is a compound annual growth rate of 1.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 424.10M | 6.48% |
Mar 27, 2024 | 398.30M | - |
Mar 26, 2024 | 398.30M | -4.05% |
Mar 25, 2024 | 415.10M | -2.72% |
Mar 22, 2024 | 426.70M | 0.76% |
Mar 21, 2024 | 423.50M | 0.17% |
Mar 20, 2024 | 422.80M | 8.63% |
Mar 19, 2024 | 389.20M | -1.07% |
Mar 18, 2024 | 393.40M | -15.49% |
Mar 15, 2024 | 465.50M | 7.31% |
Mar 14, 2024 | 433.80M | -0.85% |
Mar 13, 2024 | 437.50M | -0.70% |
Mar 12, 2024 | 440.60M | -4.03% |
Mar 11, 2024 | 459.10M | -8.40% |
Mar 8, 2024 | 501.20M | 3.98% |
Mar 7, 2024 | 482.00M | -4.76% |
Mar 6, 2024 | 506.10M | 12.34% |
Mar 5, 2024 | 450.50M | -2.02% |
Mar 4, 2024 | 459.80M | 1.79% |
Mar 1, 2024 | 451.70M | -0.13% |
Feb 29, 2024 | 452.30M | -2.27% |
Feb 28, 2024 | 462.80M | -6.26% |
Feb 27, 2024 | 493.70M | 5.67% |
Feb 26, 2024 | 467.20M | -7.01% |
Feb 23, 2024 | 502.40M | 2.78% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Oculis Holding AG | 436.50M |
Health Catalyst | 435.71M |
Sonida Senior Living | 426.50M |
Shattuck Labs | 426.32M |
Theravance Biopharma | 425.29M |
AEON Biopharma | 423.99M |
Mereo BioPharma Group | 420.73M |
Jasper Therapeutics | 420.13M |